Publications from the Centre for Immuno-Oncology
MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution.
Puttick C. et al, (2024), Nature genetics
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx.
Frankell AM. et al, (2024), Nature, 631
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Hobor S. et al, (2024), Nature communications, 15
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models.
Hynds RE. et al, (2024), Nature communications, 15
The artificial intelligence-based model ANORAK improves histopathological grading of lung adenocarcinoma.
Pan X. et al, (2024), Nature cancer, 5, 347 - 363
Fcγ receptors and immunomodulatory antibodies in cancer.
Galvez-Cancino F. et al, (2024), Nature reviews. Cancer, 24, 51 - 71
The tumour ecology of quiescence: Niches across scales of complexity.
Castillo SP. et al, (2023), Seminars in cancer biology, 92, 139 - 149
Inhibition of lactate transport by MCT-1 blockade improves chimeric antigen receptor T-cell therapy against B-cell malignancies.
Lopez E. et al, (2023), Journal for immunotherapy of cancer, 11
Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin.
Garcia-Diaz C. et al, (2023), Cell reports, 42
Antibodies against endogenous retroviruses promote lung cancer immunotherapy.
Ng KW. et al, (2023), Nature, 616, 563 - 573
Body composition and lung cancer-associated cachexia in TRACERx.
Al-Sawaf O. et al, (2023), Nature medicine, 29, 846 - 858
Evolutionary characterization of lung adenocarcinoma morphology in TRACERx.
Karasaki T. et al, (2023), Nature medicine, 29, 833 - 845
Genomic-transcriptomic evolution in lung cancer and metastasis.
Martínez-Ruiz C. et al, (2023), Nature, 616, 543 - 552
The evolution of lung cancer and impact of subclonal selection in TRACERx.
Frankell AM. et al, (2023), Nature, 616, 525 - 533
The evolution of non-small cell lung cancer metastases in TRACERx.
Al Bakir M. et al, (2023), Nature, 616, 534 - 542
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Abbosh C. et al, (2023), Nature, 616, 553 - 562
Dopaminergic Signalling Enhances IL-2 Production and Strengthens Anti-Tumour Response Exerted by Cytotoxic T Lymphocytes in a Melanoma Mouse Model.
Chovar-Vera O. et al, (2022), Cells, 11
Deciphering immunoregulatory vulnerabilities in human cancers.
Gálvez-Cancino F. et al, (2022), Nature immunology, 23, 995 - 996